Jazz Pharmaceuticals plc (JAZZ) Q1 2025 Earnings Call Transcript

  • Jazz Pharmaceuticals plc (NASDAQ:JAZZ ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Jeff Macdonald - Executive Director, Investor Relations Bruce Cozadd - Chairman and Chief Executive Officer Renee Gala - President and Chief Operating Officer Rob Iannone - Executive Vice President, Global Head of R&D and Chief Medical Officer Phil Johnson - Chief Financial Officer Conference Call Participants Jason Gerberry - Bank of America Jessica Fye - JP Morgan David Amsellem - Piper Sandler Marc Goodman - Leerink Partners. Annabel Samimy - Stifle Joseph Thome - TD Cowen Gregory Renza - RBC Capital Markets Joel Beatty - Baird Ami Fadia - Needham Ashwani Verma - UBS Mohit Bansal - Wells Fargo Gary Nachman - Raymond James Joon Lee - Truist Securities Operator Hello and thank you for standing by.